MoneyWorks4Me

The sales slipped to Rs. 434.86 millions for the March 2024 quarter as against Rs. 554.51 millions during the year-ago period.Net profit of the cmpany stood at Rs. 35.49 millions for the quarter ended March 2024 a decline of -36.65% from Rs. 56.02 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 51.56 millions from 79.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 434.86 554.51 -21.58 2087.02 2367.14 -11.83 2087.02 2367.14 -11.83
Other Income 24.87 25.59 -2.81 92.79 57.34 61.82 92.79 57.34 61.82
PBIDT 51.56 79.96 -35.52 323.46 398.85 -18.90 323.46 398.85 -18.90
Interest 2.17 1.96 10.71 8.14 4.13 97.09 8.14 4.13 97.09
PBDT 49.39 78.00 -36.68 315.32 360.13 -12.44 315.32 360.13 -12.44
Depreciation 4.03 4.79 -15.87 16.63 12.05 38.01 16.63 12.05 38.01
PBT 45.36 73.21 -38.04 298.69 348.08 -14.19 298.69 348.08 -14.19
TAX 9.87 17.19 -42.58 74.06 80.87 -8.42 74.06 80.87 -8.42
Deferred Tax -0.17 1.79 -109.50 -1.54 4.55 -133.85 -1.54 4.55 -133.85
PAT 35.49 56.02 -36.65 224.63 267.21 -15.94 224.63 267.21 -15.94
Equity 132.19 130.99 0.92 132.19 130.99 0.92 132.19 130.99 0.92
PBIDTM(%) 11.86 14.42 -17.78 15.50 16.85 -8.02 15.50 16.85 -8.02
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..